BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38065112)

  • 1. Unexpected high prevalence of hepatitis C virus infection in couples of liver transplant patients.
    Marie-Tognola M; Flores-Miranda R; Contreras AG; García-Juárez I
    Salud Publica Mex; 2023 Dec; 66(1, ene-feb):10. PubMed ID: 38065112
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis E virus infection in liver transplant recipients: a descriptive literature review.
    Perisetti A; Laoveeravat P; Inamdar S; Tharian B; Thandassery R; Goyal H
    Eur J Gastroenterol Hepatol; 2020 Aug; 32(8):916-922. PubMed ID: 32091436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Occult Hepatitis C Virus Infection in Liver Transplant Patients With Cryptogenic Cirrhosis.
    Yaghobi R; Kazemi MJ; Geramizadeh B; Malek Hosseini SA; Moayedi J
    Exp Clin Transplant; 2020 Apr; 18(2):206-209. PubMed ID: 30346262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of hepatitis C following liver transplantation.
    Rodriguez-Luna H; Douglas DD
    Curr Opin Infect Dis; 2004 Aug; 17(4):363-71. PubMed ID: 15241083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of liver transplant recipients who have chronic hepatitis C virus infection.
    Korkmaz M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():28-33. PubMed ID: 24635788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.
    Khedmat H; Taheri S
    Exp Clin Transplant; 2012 Apr; 10(2):141-7. PubMed ID: 22432758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of previous hepatitis A virus infection in renal transplant patients with hepatitis C: evidence of persistent anti-hepatitis A virus immune response.
    Mariya FA; de Mello Perez R; Silva AE; Pestana JO; Ferraz ML
    Transplant Proc; 2004 Jun; 36(5):1500-1. PubMed ID: 15251370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.
    Yosry A; Abdel-Rahman M; Esmat G; El-Serafy M; Omar A; Doss W; Zayed N; Said M; Ismail T; Hosny A; Marawan E; El-Malt O; Kamel RR; Hatata Y; El-Taweel A; Ghali A; Sabri H; Kamel S; El-Gabaly H
    Exp Clin Transplant; 2009 Sep; 7(3):157-63. PubMed ID: 19715525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis delta virus among hemodialysis and renal transplant patients.
    Pierre AMMA; Feldner ACCA; Carvalho Filho RJ; Lopes EPA; Gouvea MSG; Pinho JRR; Carvente CT; Emori CT; Silva GAD; Ferraz MLCG
    Int J Artif Organs; 2018 Mar; 41(3):171-174. PubMed ID: 29546807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
    Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
    Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan.
    Inagaki Y; Oshiro Y; Tanaka T; Yoshizumi T; Okajima H; Ishiyama K; Nakanishi C; Hidaka M; Wada H; Hibi T; Takagi K; Honda M; Kuramitsu K; Tanaka H; Tohyama T; Ikegami T; Imura S; Shimamura T; Nakayama Y; Urahashi T; Yamagishi K; Ohnishi H; Nagashima S; Takahashi M; Shirabe K; Kokudo N; Okamoto H; Ohkohchi N
    EBioMedicine; 2015 Nov; 2(11):1607-12. PubMed ID: 26870785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant.
    Shoreibah M; Orr J; Jones D; Zhang J; Venkata K; Massoud O
    Hepatol Int; 2017 Sep; 11(5):434-439. PubMed ID: 28083718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
    Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D
    Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of hepatitis C virus infection on long-term outcome in renal transplant patients.
    Ruhı Ç; Süleymanlar İ; Koçak H; Yilmaz VT; Çolak D; Dınçkan A; Gürkan A; Ersoy F; Yakupoğlu G; Süleymanlar G
    Turk J Gastroenterol; 2011; 22(2):165-70. PubMed ID: 21796553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of hepatitis B virus infection among preconception couples in South China: a cross-sectional study.
    Liang Z; Qiu J; Xiang Q; Yi J; Zhu J; Zhao Q
    BMJ Open; 2023 Jun; 13(6):e061165. PubMed ID: 37295827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection in liver allograft recipients.
    Caccamo L; Colledan M; Gridelli B; Rossi G; Doglia M; Gatti S; Ghidoni P; Lucianetti A; Lunghi G; Maggi U
    Arch Virol Suppl; 1993; 8():291-304. PubMed ID: 7505145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence, low pathogenicity of hepatitis G virus in kidney transplant recipients.
    De Filippi F; Lampertico P; Soffredini R; Rumi MG; Lunghi G; Aroldi A; Tarantino A; Ponticelli C; Colombo M
    Dig Liver Dis; 2001; 33(6):477-9. PubMed ID: 11572574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Hepatotropic Viruses Leading To Deranged Liver Function Tests in Renal Transplant Recipients.
    Asif M; Hanif FM; Luck NH; Tasneem AA
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):202-206. PubMed ID: 30777555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.